15 September 20221 minute read

AI risk assessments: Future-proofing your innovation when rules can change mid-game

Published in Chambers Expert Focus

In this episode, DLA Piper partner Danny Tobey is joined by Aviva Wein, Assistant General Counsel at Johnson & Johnson, to discuss how medical device and pharmaceutical companies are future-proofing their innovations in artificial intelligence as new regulations and risks arise.

 

Listen to the At the Intersection of Science and Law podcast on iTunesStitcher and Spotify.
Print